AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 211 filers reported holding AMICUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,538 | -56.8% | 10,735 | -55.4% | 0.00% | – |
| Q2 2023 | $302,445 | +141.1% | 24,080 | +134.4% | 0.00% | – |
| Q4 2022 | $125,433 | -60.8% | 10,273 | -62.9% | 0.00% | – |
| Q4 2021 | $320,000 | +28.0% | 27,687 | +5.6% | 0.00% | – |
| Q3 2021 | $250,000 | -25.1% | 26,228 | -24.2% | 0.00% | – |
| Q2 2021 | $334,000 | -69.5% | 34,617 | -68.8% | 0.00% | -100.0% |
| Q1 2021 | $1,095,000 | -38.9% | 110,846 | +42.8% | 0.00% | -50.0% |
| Q4 2020 | $1,793,000 | +55.5% | 77,647 | -4.9% | 0.00% | +100.0% |
| Q3 2020 | $1,153,000 | -23.0% | 81,629 | -24.6% | 0.00% | -50.0% |
| Q2 2020 | $1,497,000 | +78.2% | 108,299 | +7.0% | 0.00% | +100.0% |
| Q1 2020 | $840,000 | +3.1% | 101,169 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $815,000 | +39.3% | 99,469 | +36.4% | 0.00% | 0.0% |
| Q3 2019 | $585,000 | -16.2% | 72,947 | +30.4% | 0.00% | 0.0% |
| Q2 2019 | $698,000 | +2.3% | 55,927 | +11.5% | 0.00% | 0.0% |
| Q1 2019 | $682,000 | +87.4% | 50,180 | +31.9% | 0.00% | 0.0% |
| Q4 2018 | $364,000 | -42.9% | 38,046 | -27.8% | 0.00% | 0.0% |
| Q3 2018 | $637,000 | -26.1% | 52,712 | -4.4% | 0.00% | 0.0% |
| Q2 2018 | $862,000 | +2.1% | 55,161 | -1.7% | 0.00% | -50.0% |
| Q1 2018 | $844,000 | -69.6% | 56,125 | -70.9% | 0.00% | -60.0% |
| Q4 2017 | $2,777,000 | -3.4% | 192,978 | +1.3% | 0.01% | -16.7% |
| Q3 2017 | $2,874,000 | +1496.7% | 190,564 | +793.7% | 0.01% | +500.0% |
| Q1 2016 | $180,000 | -25.9% | 21,324 | -14.7% | 0.00% | 0.0% |
| Q4 2015 | $243,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |